Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The main purpose of this study is to begin to collect information and try to learn whether or not the combination of oxaliplatin, gemcitabine and bevacizumab works in treating women with recurrent mullerian carcinoma. We will also collect more information about the safety and side effects of this combination of drugs. Gemcitabine and oxaliplatin are chemotherapy drugs that kill cancer cells. Bevacizumab is a new anti-cancer drug that works to slow or stop cell growth in cancerous tumors by decreasing the blood supply to the tumors.
Critère d'inclusion
- Ovarian Cancer,Fallopian Tube Cancer,Primary Peritoneal Cancer